Perinatal Mental Health Care in Switzerland

• Conditions: Mental Disorder; Substance Abuse; Psychosis; Perinatal; Adaptation Reaction; Health Care Seeking Behavior; Health Care Acceptability; Panic Disorder; Post Traumatic Stress Disorder; Behavior Disorders

• Registration Number: NCT04185896
• Lead Sponsor: Bern University of Applied Sciences

Brief Summary

This qualitative study with quantitative elements examines the health care provided to women who suffered from mental disorder during pregnancy and / or in the first year after birth (i.e. during the perinatal phase). Investigators will perform individual interviews with former PMD patients, and health and social care professionals to gain insights into current health care for PMD patients.

Detailed Description

Background: Perinatal mental disorders (PMD) are highly prevalent (up to 20%), and patients use mental health care at high rates (Berger et al 2018). It is not known if the health care for PMD patients meets the needs of the patients.

Aim: The Investigators will identify factors that promote or hinder service provision and access to care, for a range of relevant PMD. The investigation will cover the user and provider perspectives.

Methods: The qualitative study consists of two complementary parts to assess user and provider perspectives. In part 1 the Investigators will conduct individual semi-structured interviews with 24 women who have had PMD. The sample will comprise of 4 clusters of relevant ICD-10 F-diagnoses, covering a wide range of mental disorders. The sample will also comprise of participants who received or did not receive mental health care before the last pregnancy. In part 2, the Investigators perform 3 focus groups (with 6-8 participants per group) with health and social care professionals, and a health-insurance delegate, to collect their experiences and perspectives on perinatal health care for PMD patients. The Investigators are guided for data collection and analysis by Levesque's et al (2013) conceptual model on access to health care.

Expected results: The study will identify barriers and facilitators for health care access (user perspective) and provision (provider perspective). The study will generate the evidence base needed to develop integrated, coordinated, patient- and family-centered care for patients with various types of PMD.

Study Timeline

• Study Start: 2019-07-10
• Study First Submitted: 2019-11-19
• Status Verified: 2019-12
• Study First Submitted QC: 2019-12-03
• Last Update Submitted: 2019-12-03
• Study First Posted: 2019-12-04
• Last Update Posted: 2019-12-04
• Primary Completion: 2020-02-29
• Study Completion: 2020-02-29

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Narratives of barriers to perinatal mental health care use	perinatal phase, i.e. pregnancy and first year after birth	Narratives of access-inhibiting factors, in semi-structured individual interviews with former PMD patients
Narratives of mentions of barriers to perinatal mental health care provision	Perinatal phase, i.e. pregnancy and first year after birth	Narratives of provision-inhibiting factors, in focus group interviews with health and social care providers
Narratives of mentions of facilitators of perinatal mental health care use	Perinatal phase, i.e. pregnancy and first year after birth	Narratives of access-promoting factors, in semi-structured individual interviews with former PMD patients
Narratives of mentions of facilitators of perinatal mental health care provision	Perinatal phase, i.e. pregnancy and first year after birth	Narratives of provision-promoting factors, in focus group interviews with health and social care providers

Secondary Outcome Measures

Name	Time	Method
Sociodemographic data of participating health care professionals	2019-2020	Sociodemographic data of participating health care professionals
Sociodemographic data of participating affected PMD patients	2019-2020	Sociodemographic data of participating affected PMD patients

Trial Locations

Locations (1)

Anke Berger; 🇨🇭 Bern, Switzerland